Posted 17th June 2020 by Liv Sewell
Almost five years ago, the plan to implement a wide-ranging digital pathology approach across the Netherlands began to take shape. As more labs across the country acquire digital pathology capability, with steps to create a strong and accessible image repository and a national image exchange platform, one of the project leaders, Professor Katrien Grünberg, offered an update and spoke of some challenges that still lie ahead.
Posted 10th June 2020 by Liv Sewell
Bringing molecular and digital pathology closer together through a more integrative approach can lead to clear advantages for diagnostic and research workflows.
Posted 3rd June 2020 by Liv Sewell
Computational pathology has increased applications for diagnosis, prediction of prognosis and therapy response, facilitating the movement of healthcare towards personalised medicine.
Coupled with deep learning, such tools are ever more efficient and robust within research and clinical settings.
Posted 27th May 2020 by Liv Sewell
The present COVID-19 crisis has demonstrated the vital need for knowledge sharing across the global science community. We asked three of our speakers what international collaboration means for them as leaders in their fields.
Posted 20th May 2020 by Joshua Sewell
This article is republished with kind permission from BioVox.
Recent activities in the cell therapy field have prompted many investment funds to pour fresh and increasing capital into this space. In this review, we would like to share some observations and highlight a few of the questions that arise when new modalities cross the bridge from bench to bed.
Posted 15th May 2020 by Joshua Sewell
Check out this guide to learn more about the potential impact of blockchains on the medical and healthcare sectors.
Posted 13th May 2020 by Liv Sewell
NASH is thought to affect 25% of the global population and is a primary risk factor for Hepatocellular carcinoma (HCC) – the second most common cause of cancer deaths worldwide. Understanding the aetiology of NAFLD progression, developing non-invasive diagnostic tests and developing treatments are urgent priorities.
Posted 11th May 2020 by Liv Sewell
International collaboration and travel are integral to the life of researchers and biotechnology professionals. But coronavirus has made travel impossible.
We look back over two decades of growth in international scientific collaboration to understand the extent of the effects of reduced mobility and consider what collaboration will look like in the foreseeable future.